STEMCELL-TECHNOLOGIES
STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit has been granted de novo classification by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240326396951/en/
STEMCELL Technologies is pleased to announce that its new EasySep™ Human Bone Marrow CD138 Positive Selection Kit is now classified by the U.S. Food and Drug Administration (FDA) as a first-of-its-kind in vitro diagnostic (IVD) medical device for hematopoietic cell enrichment. (Photo: Business Wire)
The kit can be used to enrich plasma cells expressing the CD138 marker (CD138+ cells) from patient bone marrow samples. Such cell-type-specific enrichment can increase the sensitivity of downstream in vitro diagnostic tests for multiple myeloma—a cancer of plasma cells—to better inform patient risk and course of treatment. Accounting for approximately 2% of all cancers in the United States1, multiple myeloma is incurable, and variable or low frequencies of CD138+ cells in bone marrow samples can impact the reliability of detecting genetic abnormalities that influence the disease’s progression. Incorporation of STEMCELL's new kit in a pre-analytical step of the diagnostic workflow can contribute to improving patient care and outcomes by enhancing the sensitivity and resolution of these downstream assays.
“STEMCELL is proud to develop the first hematopoietic cell enrichment product identified as an in vitro diagnostic device by the FDA,” said Dr. Allen Eaves, President and CEO, STEMCELL. “Creating an IVD product that improves the accuracy of information guiding the treatment of patients with multiple myeloma is a milestone achievement that reflects our commitment to make a positive impact on human health.”
The FDA identifies this new product type as a hematopoietic cell enrichment kit: a Class II IVD device for selecting specific cells from human whole blood or bone marrow, intended for use with diagnostic assays as part of the pre-analytical workflow. Agencies such as the National Comprehensive Cancer Network and the American College of Medical Genetics recommend CD138+ cell enrichment upstream of fluorescence in situ hybridization (FISH) testing for multiple myeloma; however, until now, hematopoietic cell enrichment products have not been classified as IVD devices by the FDA.
“This De Novo classification will have a permanent impact on the IVD landscape and paves the way for further innovation,” said Dr. Eaves. “STEMCELL is committed to building on this foundational work in the IVD field with novel diagnostic products and support, including supporting industry partnerships through our Diagnostics Partnerships and OEM Solutions Program.”
The EasySep™ Human Bone Marrow CD138 Positive Selection Kit is part of STEMCELL’s portfolio of EasySep™ immunomagnetic cell isolation technologies, specifically developed for fast and easy isolation of highly purified cells that are ready for downstream applications. It marks the culmination of many years of work, which included examining more than 230 bone marrow aspirates from multiple myeloma patients, precision studies of inter- and intra-laboratory reproducibility, and limit of detection and interference studies. The EasySep™ Human Bone Marrow CD138 Positive Selection Kit will be available for sale in the United States, the European Union, Canada, and the United Kingdom.
1Padala et al. 2021 Med Sci (Basel)
About STEMCELL Technologies
STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240326396951/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Foresight Launches the First Conversational AI Interface to Query Unified Private Market Data23.10.2025 14:07:00 CEST | Press release
From deal sourcing to portfolio management, Foresight is shaping the future of how the private market engages with data Foresight is ushering in the next generation of private market software by letting its customers use natural language to query their unified pre- and post-deal data. Today, the company announced new AI capabilities that will give customers the ability to ask questions within the Foresight platform as well as in ChatGPT, Claude, and Glean through its new model context protocol (MCP) server. Private market dealmakers will be able to prompt Foresight’s AI for lists of prospective companies, and anyone who makes post-deal decisions will be able to ask portfolio questions, model scenarios, and execute workflows in natural language on Foresight’s desktop or mobile interfaces. “The $15 trillion private market has run on data silos and Excel, which has created unnecessary opacity. Foresight unlocks the data and analytics that fund managers and financial institutions need by u
Adtran launches industry-first Galileo OSNMA authentication for Oscilloquartz timing solutions23.10.2025 14:00:00 CEST | Press release
News summary: GNSS timing underpins 5G, finance and data centers, yet spoofing and signal manipulation threaten accuracy, reliability and trust Adtran’s Oscilloquartz technology now supports Galileo OSNMA, a new authentication service that verifies GNSS signals First-to-market timing innovation boosts GNSS resilience, helps futureproof deployments and sets a new benchmark for timing security Adtran today announced support for Galileo’s Open Service Navigation Message Authentication (OSNMA) across its Oscilloquartz synchronization platforms, marking a major advance in GNSS security. OSNMA is the first GNSS authentication service designed for civilian use, and Adtran is the first in the timing industry to support it. By verifying that timing data originates from genuine Galileo satellites, OSNMA ensures authenticity and integrity at the point of reception. Available via firmware update for supported multi-band GNSS receivers, the new feature adds an extra layer of protection against spoo
The Next Era of Ownership Begins with the All New Ledger Nano™ and Ledger Wallet™23.10.2025 14:00:00 CEST | Press release
The all new Ledger Nano™ reinvents the iconic signer for a new era, securing Ledger Wallet™ and putting you in control, free from compromise. Ledger™, the world leader in digital asset security for consumers and enterprises, today unveiled a new era for Ledger, ownership, and identity. At Ledger Op3n in Paris, Ledger launched the new Ledger Nano™ Gen5, recreated and expanded Ledger Live™ as Ledger Wallet™, and introduced Ledger Multisig. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023549325/en/ As society transitions to digital identities, challenged by AI and a blurring of physical and online worlds, authenticating what's true is critical. Ledger is redefining its products to meet this future head-on, building products to enable Proof of You and Proof of Authority at scale. Ledger’s secure devices, formerly known as hardware wallets, are now Ledger signers. This update reflects their expanded role beyond securing fina
CEOs Worldwide Show Rising Confidence and Unprecedented Adaptability Amid Unrelenting Uncertainty23.10.2025 14:00:00 CEST | Press release
Egon Zehnder’s global study of 1,235 CEOs finds leaders emerging more resilient and future focused Global CEOs are meeting ongoing volatility with renewed confidence and agility, according to The CEO Response, Egon Zehnder’s latest study of 1,235 chief executives. The research reveals that 92% of CEOs believe they must cultivate unprecedented levels of adaptability to lead effectively through current geopolitical and economic disruption. Yet most feel more capable and confident than a year ago, having turned recent crises into lasting lessons in resilience. “CEOs are increasingly adjusting to the rapidly changing world order, characterized by fragmented alliances, strategic resource shortages, new technologies, and the power of individual actors,” said Lars-Hendrik Röller, Founder and Chair of the Berlin Global Dialogue. “They are guided by a key insight: Either they help shape the rules of the new order—or they are completely exposed to its complex developments.” Nearly six in ten CEO
Vodafone Spain and Twilio Partner to Offer Secure and Interactive RCS Messaging to Businesses in Spain23.10.2025 10:00:00 CEST | Press release
81% of consumers prefer RCS over SMS, and 71% of businesses plan to adopt it in the next year. Twilio, the customer engagement platform that powers personalised, real-time experiences for today's leading brands, has announced an extended partnership with Vodafone Spain, one of the country's leading telecommunications operators. This will enable Spanish businesses to access Rich Communication Services (RCS) messaging, revolutionising the way they interact with their customers through rich, interactive and secure communications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251023623745/en/ Vodafone Spain has relied on Twilio's global expertise to accelerate the adoption of this next-generation messaging solution, positioning it as the new standard for business communication in the Spanish market. A much needed evolution for mobile communication In a world where personalisation and trust are essential for brand to consumer re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom